Canine parvovirus (CPV) is the most important enteric virus for dogs and it seems to be undergoing 
INTRODUCTION
Since its emergence in the late 1970s, canine parvovirus (CPV) has become one of the most common viruses to cause acute enteric clinical signs (such as vomiting, anorexia, lethargy and diarrhea, with or without melena) in young dogs up to 6 months old worldwide, despite of vaccination program (12, 15) . (2) . At present, CPV-2c is broadly distributed in Italy (16) , and has also been found in Spain (8) , Germany, the United Kingdom (9), the United States (13), Australia (17) , and Portugal (27) . Although the first reports seemed to show a low pathogenicity for CPV-2c, experimental data and field observations now indicate that a more severe clinical course with higher mortality rates is associated with CPV-2c infection (10) .
This variant has already been detected in South America, specifically in Argentina (3) and Uruguay (23) , from stool samples of hemorrhagic enteritis in dogs. This new variant was also recently found in fecal samples from diarrheic dogs from the Southern region of Brazil (24) .
In the state of Rio de Janeiro, Southeastern Brazil, previous reports have shown that CPV is responsible for approximately 46% of the enteritis cases in puppies (4, 6, 7) .
As CPV appears to be undergoing continuous evolution, the main objective of this study was to monitor the distribution of CPV variants in Rio de Janeiro. In addition, the clinical features associated with the different variants were also investigated.
MATERIALS AND METHODS
A total of 32 fecal samples collected from unvaccinated puppies (16 females and 16 males) less than nine months old presenting diarrhea were analyzed. CPV diagnosis were confirmed by hemagglutination/hemagglutination-inhibiton (HA/HI) tests (7) and polymerase chain reaction assay (PCR) by using the set of primers P2ab, located at nt 3025-3045 and 3685-3706 (within VP2 gene) that detects the new CPV types (5, 25) . html), and the sequences were compared with those available from GenBank ( Table 1 ). All of the sequences generated in this study were deposited in GenBank (accession numbers:
DNA extracted from commercially available vaccines currently used in Brazil: Vanguard®, Pfizer (CPV-2) and Duramune® Max5, FortDodge (CPV-2b) were also submitted to sequence analysis and used as positive control. DNA extrated from Milli-Q water was used as negative control.
RESULTS
For CPV typing, the differences in aa 426 (nt 4062-64)
were analyzed by sequencing ( In many ways, the epidemiological history of CPV in
Brazil resembles those seen in other countries due to a constant process of rapid antigenic-type replacement by more adaptaded strains and the evolution of viral strains over time (9, 22, 19) .
The reasons for the type distribution could be related to replicative advantages in the host cell or to more efficient virus shedding in the feces.
Non-synonymous and synonymous mutations at residue 440 (nt 4104) have been described in CPV strains isolated from other countries, such as Italy (1), the United States (13, 14) , and Korea (18), and in two CPV-2a Brazilian strains collected in 1993 and 2002 (22) .
In this study, a synonymous mutation (an A insertion) at residue 440 was observed in stool samples collected after
2004. This residue is located on an exposed region at the surface of the viral capsid, and a greater variability between parvoviruses has been observed in this antigenic region (1).
Another synonymous mutation at residue 574 (an A-G substitution at nt 5408) was detected in both 2a and 2b CPV types after 1998, and changes in this residue have not been previously described. The exact phenotypic consequence of this mutation is not clear, but it has been sustained in the canine population since 1998 and may represent a local adaptation of CPV strains.
The onset of clinical signs that are similar to those of canine parvovirus (anorexia, lethargy, vomiting, and hemorrhagic fluid diarrhea) is a frequent finding in veterinary practice (4, 11, 18) . The field pathogenicity of the new strain, CPV-2c, has been investigated, and most of the CPV-2c cases reported had clinical signs associated with severe hemorrhagic enteritis, in some cases resulting in a fatal outcome (8, 14) . Sequencing of canine parvovirus However, the CPV-2c strain detected in this study was collected from a puppy with mild clinical signs.
Studies that investigated the pathogenicity of the other variants ("new CPV-2a" and 2b) also showed conflicting results. There are some reports suggesting that CPV-2b may cause a milder disease than CPV-2a viruses (17, 18) ; however, both CPV-2a and 2b have been detected in animals with severe diarrhea (14) . Although the main purpose of this study was the genomic typing of CPV strains circulating in Rio de Janeiro, it should be noted that most of the "new CPV-2a" samples (16/19) were collected from puppies with a more severe enteric disease.
Our results demonstrate that, despite its DNA genome, 
